ALMS Alumis Inc. - Common Stock
$25.56
价格 · 八月 19, 2026
截至...的财报数据 八月 13, 2026
52周区间
$4–$31
79% of range
分析师评级
STRONG BUY
16 analysts
目标价
$40
+58% upside
P/E (TTM)
-3.4
ROE
-61.9%
净利润率
-1011.8%
ALMS 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$25.55
市值
—
P/E (TTM)
-3.4
每股收益 (TTM)
$-2.86
营收 (TTM)
$24M
股息收益率
—
ROE
-61.9%
负债/权益
—
52周区间
$4 – $31
ALMS 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$24M
2025-12-31
→
2025-12-31
EPS
$-2.86
2023-12-31
→
2025-12-31
自由现金流
$-370M
2025-12-31
→
2025-12-31
利润率
-1011.8%
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜?
指标
5年趋势
ALMS
同行中位数
P/E (TTM)
-3.4
38.7
盈利能力 毛利率、营业利润率和净利率;股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
ALMS
同行中位数
Operating Margin (营业利润率)
-1886.9%
—
Net Profit Margin (净利润率)
-1011.8%
15.3%
ROA
-64.6%
-6.4%
ROE
-61.9%
-16.8%
ROIC
-145.5%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
ALMS
同行中位数
Current Ratio (流动比率)
4.3
12.8
Quick Ratio (速动比率)
4.2
—
成长 营收、每股收益 (EPS) 和净利润增长:同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
ALMS
同行中位数
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
ALMS
同行中位数
ALMS 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
16 位分析师
- 强烈买入 8 50.0%
- 买入 6 37.5%
- 持有 2 12.5%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
9 位分析师 · 2026-08-19
中位数
$39.00
现在
$25.55
最低
$25.00
最高
$55.00
中位数目标
$39.00
+52.6%
平均目标
$40.33
+57.8%
收益历史 每股收益实际值 vs 预估值,惊喜%,达标率,下次财报日期
平均惊喜
0.10%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年3月31日 | $-0.74 | $-0.78 | 0.04% |
| 2025年12月31日 | $-0.94 | $-1.00 | 0.06% |
| 2025年9月30日 | $-1.06 | $-0.93 | -0.13% |
| 2025年6月30日 | $-1.68 | $-1.41 | -0.27% |
| 2025年3月31日 | $-1.82 | $-1.52 | -0.30% |
| 2024年12月31日 | $-0.23 | $-1.42 | 1.2% |
同行比较(GICS 子行业) 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| ALMS | — | -3.4 | — | -1011.8% | -61.9% | — |
| GPCR | $14.78B | -86.9 | — | — | -12.3% | — |
| OGN | $1.87B | 10.0 | -2.9% | 3.0% | 25.2% | 53.3% |
| MBX | $1.42B | -13.3 | — | — | -29.6% | — |
| TARS | $3.48B | -51.5 | 146.7% | -14.7% | -19.7% | — |
| SUPN | $2.86B | -73.1 | 8.6% | -5.4% | -3.6% | — |
| ATAI | $223M | -1.4 | -1.9% | -48464.0% | -83.1% | — |
| TRVI | $1.61B | -39.1 | — | — | -22.4% | — |
| NUVB | $3.03B | -14.9 | 699.0% | -325.3% | -60.3% | — |
| NKTR | $862M | -4.3 | -43.9% | -297.1% | -500.1% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 14
| 指标 | 趋势 | 2025 |
|---|---|---|
| Revenue | $24M | |
| R&D Expense | $386M | |
| SG&A Expense | $92M | |
| Operating Expenses | $478M | |
| Operating Income | $-454M | |
| Other Non-op | $-169.0K | |
| Pretax Income | $-252M | |
| Income Tax | $-9M | |
| Net Income | $-243M | |
| EPS (Basic) | $-2.86 | |
| EPS (Diluted) | $-2.86 | |
| Shares (Basic) | 85,029,624 | |
| Shares (Diluted) | 85,029,624 | |
| EBITDA | $-450M |
资产负债表 20
| 指标 | 趋势 | 2025 |
|---|---|---|
| Cash & Equivalents | $90M | |
| Short-term Investments | $219M | |
| Prepaid Expense | $7M | |
| Current Assets | $318M | |
| PP&E (Net) | $18M | |
| PP&E (Gross) | $26M | |
| Accum. Depreciation | $8M | |
| Other Non-current Assets | $6M | |
| Total Assets | $412M | |
| Accounts Payable | $10M | |
| Current Liabilities | $73M | |
| Capital Leases | $32M | |
| Deferred Tax | $2M | |
| Other Non-current Liabilities | $207.0K | |
| Total Liabilities | $111M | |
| Paid-in Capital | $1.20B | |
| Retained Earnings | $-902M | |
| AOCI | $188.0K | |
| Stockholders' Equity | $301M | |
| Liabilities + Equity | $412M |
现金流 11
| 指标 | 趋势 | 2025 |
|---|---|---|
| D&A | $3M | |
| Stock-based Comp | $44M | |
| Deferred Tax | $-9M | |
| Other Non-cash | $-165M | |
| Operating Cash Flow | $-370M | |
| CapEx | $653.0K | |
| Investing Cash Flow | $288M | |
| Stock Repurchased | $17.0K | |
| Net Stock Activity | $-17.0K | |
| Financing Cash Flow | $2M | |
| Free Cash Flow | $-370M |
盈利能力 7
| 指标 | 趋势 | 2025 |
|---|---|---|
| Operating Margin | -1886.9% | |
| Net Margin | -1011.8% | |
| Pretax Margin | -1047.3% | |
| EBITDA Margin | -1872.4% | |
| ROA | -64.6% | |
| ROE | -61.9% | |
| ROIC | -145.5% |
流动性与偿付能力 2
| 指标 | 趋势 | 2025 |
|---|---|---|
| Current Ratio | 4.3 | |
| Quick Ratio | 4.2 |
效率 1
| 指标 | 趋势 | 2025 |
|---|---|---|
| Asset Turnover | 0.1 |
估值 (TTM) 4
| 指标 | 趋势 | 2025 |
|---|---|---|
| Revenue TTM | $24M | |
| Net Income TTM | $-243M | |
| P/E | -3.4 | |
| Earnings Yield | -29.3% |
损益表 14
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $2M | $2M | $2M | $2M | $3M | $17M | |
| R&D Expense | $85M | $82M | $83M | $98M | $109M | $97M | |
| SG&A Expense | $23M | $19M | $16M | $20M | $34M | $22M | |
| Operating Expenses | $151M | $100M | $98M | $117M | $143M | $119M | |
| Operating Income | $-149M | $-98M | $-96M | $-115M | $-141M | $-102M | |
| Other Non-op | $-71.0K | $7.0K | $-33.0K | $-54.0K | $-38.0K | $-44.0K | |
| Pretax Income | $-144M | · | $-93M | $-111M | $51M | · | |
| Income Tax | $-2M | · | $0 | $0 | $-9M | · | |
| Net Income | $-142M | $-93M | $-93M | $-111M | $59M | $-99M | |
| EPS (Basic) | $-1.11 | $-0.74 | $-0.76 | $-1.06 | $0.78 | $-1.82 | |
| EPS (Diluted) | $-1.11 | $-0.74 | $-0.75 | $-1.06 | $0.77 | $-1.82 | |
| Shares (Basic) | 127,690,254 | 125,050,645 | -149,837,027 | 104,109,243 | 76,477,144 | 54,280,264 | |
| Shares (Diluted) | 127,690,254 | 125,050,645 | -149,995,778 | 104,109,243 | 76,635,895 | 65,440,021 | |
| EBITDA | $-149M | $-98M | · | $-115M | $-141M | $-101M |
资产负债表 20
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $64M | $64M | $90M | $65M | $152M | $129M | |
| Short-term Investments | · | · | $219M | $312M | $335M | $80M | |
| Prepaid Expense | $7M | $6M | $7M | $11M | $24M | $4M | |
| Current Assets | $514M | $532M | $318M | $393M | $518M | $226M | |
| PP&E (Net) | $17M | $18M | $18M | $19M | $20M | $20M | |
| PP&E (Gross) | $27M | $26M | $26M | $26M | $27M | $26M | |
| Accum. Depreciation | $10M | $9M | $8M | $7M | $7M | $5M | |
| Other Non-current Assets | $2M | $7M | $6M | $6M | $2M | $45.0K | |
| Total Assets | $561M | $672M | $412M | $488M | $611M | $261M | |
| Accounts Payable | $13M | $12M | $10M | $5M | $15M | $7M | |
| Current Liabilities | $76M | $71M | $73M | $65M | $86M | $60M | |
| Capital Leases | $32M | $31M | $32M | $33M | $35M | $29M | |
| Deferred Tax | $383.0K | $2M | $2M | $2M | $2M | · | |
| Other Non-current Liabilities | $168.0K | $207.0K | $207.0K | $169.0K | $168.0K | · | |
| Total Liabilities | $108M | $105M | $111M | $103M | $126M | $93M | |
| Paid-in Capital | $1.59B | $1.56B | $1.20B | $1.19B | $1.18B | $926M | |
| Retained Earnings | $-1.14B | $-995M | $-902M | $-809M | $-698M | $-758M | |
| AOCI | $-683.0K | $-467.0K | $188.0K | $234.0K | $22.0K | $-8.0K | |
| Stockholders' Equity | $452M | $567M | $301M | $385M | $485M | $168M | |
| Liabilities + Equity | $561M | $672M | $412M | $488M | $611M | $261M |
现金流 11
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| D&A | $874.0K | $871.0K | $867.0K | $916.0K | $870.0K | $843.0K | |
| Stock-based Comp | $14M | $12M | $8M | $10M | $19M | $7M | |
| Other Non-cash | · | $-7M | · | · | · | $11M | |
| Operating Cash Flow | $-82M | $-87M | $-72M | $-111M | $-106M | $-80M | |
| CapEx | $237.0K | $164.0K | $0 | $0 | $616.0K | $37.0K | |
| Investing Cash Flow | $69M | $-286M | $95M | $24M | $129M | $39M | |
| Stock Issued | $0 | $324M | · | · | · | · | |
| Stock Repurchased | · | · | $0 | $0 | · | · | |
| Net Stock Activity | · | $324M | · | · | · | · | |
| Financing Cash Flow | $13M | $347M | $1M | $0 | · | · | |
| Free Cash Flow | · | $-87M | · | · | · | $-80M |
盈利能力 7
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -8956.4% | -5652.4% | · | -5580.4% | -5271.5% | -583.9% | |
| Net Margin | -8557.2% | -5344.8% | · | -5360.7% | 2225.1% | -569.1% | |
| Pretax Margin | -8662.9% | · | · | -5360.7% | 1904.0% | · | |
| EBITDA Margin | -8956.4% | -5602.4% | · | -5580.4% | -5271.5% | -579.0% | |
| ROA | -24.3% | -20.0% | · | -24.6% | 13.5% | -75.8% | |
| ROE | -30.3% | -25.3% | · | -30.2% | 254.8% | -117.6% | |
| ROIC | -32.5% | · | · | -30.0% | -33.8% | · |
流动性与偿付能力 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 6.7 | 7.5 | · | 6.0 | 6.0 | 3.7 | |
| Quick Ratio | 0.8 | 0.9 | · | 5.8 | 5.7 | 3.5 |
效率 1
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.1 |
估值 (TTM) 4
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | $24M | · | · | · | · | |
| Net Income TTM | $-287M | $-243M | · | $-244M | $-189M | $-298M | |
| P/E | -13.1 | -7.7 | · | -1.0 | -0.1 | -0.1 | |
| Earnings Yield | -7.6% | -12.9% | · | -96.2% | -862.7% | -776.6% |
财务报表 损益表、资产负债表、现金流量表 — 年度,近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| 收入 | $24M | — | — |
| 营业利润率 % | -1886.9% | — | — |
| 净收入 | $-243M | $-294M | $-155M |
| 稀释后每股收益 (EPS) | $-2.86 | $-10.38 | $-72.08 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| 流动比率 | 4.3 | — | — |
| 速动比率 | 4.2 | — | — |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| 自由现金流 | $-370M | — | — |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存,并会跟随您浏览所有股票。
机构持有人 (13F) 220 家申报者 · $2.8B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸;单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存,而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 32 (-60 与上一季度对比) | 20 (-1 与上一季度对比) | 75 (+13 与上一季度对比) | 64 (+30 与上一季度对比) | +12.9M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天,外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过,优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| AyurMaya Capital Management Company, LP | $426031355 | 15139707 | 15.31% | 股份 |
| Deep Track Capital, LP | $178648422 | 6348558 | 6.42% | 股份 |
| SAMSARA BIOCAPITAL, LLC | $178554463 | 6345219 | 6.42% | 股份 |
| FMR LLC | $167396981 | 5948720 | 6.02% | 股份 |
| Foresite Capital Management V, LLC | $165941439 | 5896995 | 5.96% | 股份 |
| venBio Partners LLC | $127429401 | 4528408 | 4.58% | 股份 |
| Foresite Capital Management VI LLC | $119529434 | 4247670 | 4.30% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $118629882 | 4215703 | 4.26% | 股份 |
| Nextech Invest Ltd. | $99643684 | 3540998 | 3.58% | 股份 |
| Cormorant Asset Management, LP | $92456671 | 3285596 | 3.32% | 股份 |
| Saturn V Capital Management LP | $82040566 | 2915443 | 2.95% | 股份 |
| Octagon Capital Advisors LP | $79655898 | 2830700 | 2.86% | 股份 |
| STATE STREET CORP | $61549665 | 2187266 | 2.21% | 股份 |
| MPM BIOIMPACT LLC | $56815223 | 2019020 | 2.04% | 股份 |
| BAKER BROS. ADVISORS LP | $56631750 | 2012500 | 2.04% | 股份 |
| SR One Capital Management, LP | $55151473 | 1959896 | 1.98% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $52423177 | 1862525 | 1.88% | 股份 |
| JANUS HENDERSON GROUP PLC | $46151361 | 2095408 | 1.66% | 股份 |
| NOVO HOLDINGS A/S | $30954000 | 1100000 | 1.11% | 股份 |
| PRINCIPAL FINANCIAL GROUP INC | $29885271 | 1062021 | 1.07% | 股份 |
| D. E. Shaw & Co., Inc. | $27246105 | 968234 | 0.98% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $25922878 | 921211 | 0.93% | 股份 |
| Ikarian Capital, LLC | $24497220 | 870548 | 0.88% | 股份 |
| GREAT POINT PARTNERS LLC | $24089557 | 856061 | 0.87% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $19701771 | 700134 | 0.71% | 股份 |
| Integral Health Asset Management, LLC | $19698000 | 700000 | 0.71% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $18576396 | 660142 | 0.67% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $17221961 | 612010 | 0.62% | 股份 |
| Opaleye Management Inc. | $15477000 | 550000 | 0.56% | 股份 |
| ORBIMED ADVISORS LLC | $15425307 | 548163 | 0.55% | 股份 |
| GOLDMAN SACHS GROUP INC | $15172778 | 539189 | 0.55% | 股份 |
| ROYCE & ASSOCIATES LP | $14782026 | 525303 | 0.53% | 股份 |
| Woodline Partners LP | $13677503 | 486052 | 0.49% | 股份 |
| Nextech Invest Ltd. | $11609204 | 1476998 | 0.42% | 股份 |
| Spruce Street Capital LP | $11047032 | 392574 | 0.40% | 股份 |
| Trium Capital LLP | $10982142 | 390268 | 0.39% | 股份 |
| CITIGROUP INC | $10697196 | 380142 | 0.38% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $10583989 | 376119 | 0.38% | 股份 |
| Ikarian Capital, LLC | $10026282 | 356300 | 0.36% | 买入期权 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $9029029 | 320861 | 0.32% | 股份 |
| Weiss Asset Management LP | $8761980 | 311371 | 0.31% | 股份 |
| Artia Global Partners LP | $7838284 | 278546 | 0.28% | 股份 |
| Yu Fan | $7110190 | 252672 | 0.26% | 股份 |
| BOOTHBAY FUND MANAGEMENT, LLC | $6825019 | 242538 | 0.25% | 股份 |
| Omega Fund Management, LLC | $6788916 | 241255 | 0.24% | 股份 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $6413806 | 236323 | 0.23% | 股份 |
| TOWERVIEW LLC | $6255353 | 222294 | 0.22% | 股份 |
| JPMORGAN CHASE & CO | $5970230 | 216591 | 0.21% | 股份 |
| Exome Asset Management LLC | $5752323 | 204418 | 0.21% | 股份 |
| DIADEMA PARTNERS LP | $5628000 | 200000 | 0.20% | 买入期权 |
| HighVista Strategies LLC | $5627100 | 199968 | 0.20% | 股份 |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | $5583008 | 1399250 | 0.20% | 股份 |
| MARSHALL WACE, LLP | $5458767 | 193986 | 0.20% | 股份 |
| BANK OF AMERICA CORP /DE/ | $5409184 | 192224 | 0.19% | 股份 |
| Susquehanna Portfolio Strategies, LLC | $4862001 | 172779 | 0.17% | 股份 |
| BlackRock, Inc. | $4784841 | 170037 | 0.17% | 股份 |
| Ensign Peak Advisors, Inc | $4135736 | 146970 | 0.15% | 股份 |
| VANGUARD GROUP INC | $3906303 | 400236 | 0.14% | 股份 |
| MOORE CAPITAL MANAGEMENT, LP | $3849636 | 136803 | 0.14% | 股份 |
| Swiss National Bank | $3824226 | 135900 | 0.14% | 股份 |
| STEMPOINT CAPITAL LP | $3819611 | 135736 | 0.14% | 股份 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $3795000 | 134850 | 0.14% | 股份 |
| VICTORY CAPITAL MANAGEMENT INC | $3723794 | 132331 | 0.13% | 股份 |
| Quantinno Capital Management LP | $3688929 | 131092 | 0.13% | 股份 |
| Elmind Capital, LP | $3658200 | 130000 | 0.13% | 股份 |
| PRUDENTIAL FINANCIAL INC | $3474812 | 123483 | 0.12% | 股份 |
| WELLS FARGO & COMPANY/MN | $3145377 | 111776 | 0.11% | 股份 |
| STIFEL FINANCIAL CORP | $3097510 | 110075 | 0.11% | 股份 |
| BOOTHBAY FUND MANAGEMENT, LLC | $2943444 | 104600 | 0.11% | 买入期权 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $2820050 | 100215 | 0.10% | 股份 |
| Caption Management, LLC | $2814000 | 100000 | 0.10% | 买入期权 |
| Ghisallo Capital Management LLC | $2814000 | 100000 | 0.10% | 股份 |
| TD Asset Management Inc | $2729636 | 97002 | 0.10% | 股份 |
| RHUMBLINE ADVISERS | $2723010 | 96767 | 0.10% | 股份 |
| FIRST TRUST ADVISORS LP | $2646454 | 94046 | 0.10% | 股份 |
| Harvest Investment Services, LLC | $2610407 | 92765 | 0.09% | 股份 |
| BARCLAYS PLC | $2596309 | 92264 | 0.09% | 股份 |
| Caption Management, LLC | $2532600 | 90000 | 0.09% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2490390 | 88500 | 0.09% | 买入期权 |
| ALLIANCEBERNSTEIN L.P. | $2299800 | 104394 | 0.08% | 股份 |
| Ally Bridge Group (NY) LLC | $2151556 | 76459 | 0.08% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2040150 | 72500 | 0.07% | 卖出期权 |
| Mariner, LLC | $2018263 | 71726 | 0.07% | 股份 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1781015 | 80845 | 0.06% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $1725657 | 61324 | 0.06% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1652296 | 58717 | 0.06% | 股份 |
| ALGERT GLOBAL LLC | $1625648 | 57770 | 0.06% | 股份 |
| CITADEL ADVISORS LLC | $1581468 | 56200 | 0.06% | 买入期权 |
| ACT CAPITAL MANAGEMENT, LLC | $1452024 | 51600 | 0.05% | 股份 |
| VANGUARD ASSET MANAGEMENT, Ltd | $1424306 | 50615 | 0.05% | 股份 |
| STATE OF WISCONSIN INVESTMENT BOARD | $1418622 | 50413 | 0.05% | 股份 |
| Vanguard Global Advisers, LLC | $1400134 | 49756 | 0.05% | 股份 |
| Squarepoint Ops LLC | $1339183 | 47590 | 0.05% | 股份 |
| MetLife Investment Management, LLC | $1303220 | 46312 | 0.05% | 股份 |
| CITADEL ADVISORS LLC | $1224090 | 43500 | 0.04% | 卖出期权 |
| FRED ALGER MANAGEMENT, LLC | $1211624 | 43057 | 0.04% | 股份 |
| JANE STREET GROUP, LLC | $1136856 | 40400 | 0.04% | 卖出期权 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1023536 | 36373 | 0.04% | 股份 |
| Corient Private Wealth LP | $997142 | 35435 | 0.04% | 股份 |
| Trexquant Investment LP | $960615 | 34137 | 0.03% | 股份 |
公司内部人士 12 位内幕人士 · 0 位高管 · 6 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Lynn A. Tetrault | 董事 | 2026年6月30日 A | 3553 | 0 | 0 | $0 |
| Sapna Srivastava | 董事 | 2026年6月30日 A | 3553 | 0 | 0 | $0 |
| Zhengbin Yao | 董事 | 2026年6月30日 A | 27082 | 0 | 0 | $0 |
| Patrick Machado | 董事 | 2026年6月30日 A | 3553 | 0 | 0 | $0 |
| Srinivas Akkaraju | 董事 | 2026年6月30日 A | 3553 | 15 | 0 | $19069488 |
| James B. Tananbaum | 董事 | 2026年4月1日 J | 680486 | 7 | 0 | $10627638 |
| Sanam Pangali | — | 2026年8月3日 S | 9747 | 0 | 2 | $-175969 |
| Mark Christopher Bradley | — | 2026年8月3日 S | 48533 | 0 | 1 | $-67824 |
| Jorn Drappa | — | 2026年8月3日 S | 56892 | 0 | 1 | $-64527 |
| David M Goldstein | — | 2026年8月3日 S | 30970 | 0 | 1 | $-68457 |
| John R. Schroer | — | 2026年8月3日 S | 24718 | 0 | 1 | $-86546 |
| Roy C. Hardiman | — | 2026年8月3日 S | 207746 | 0 | 1 | $-70988 |
来自SEC表格3/4/5申报的内部人士;净额=仅公开市场买卖
激进投资者及 5%+ 股东 4 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权,意图影响发行人(激进股东持股、董事会活动、并购)。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Foresite Capital Fund VI LP, Foresite Capital Management VI, LLC, Foresite Capital Fund V, L.P., Foresite Capital Management V, LLC, Foresite Capital Opportunity Fund V, L.P., Foresite Capital Opportunity Management V, LLC, James B. Tananbaum ×5 申报 | 2026年8月17日 | 14.50% | 初始申报 | 被动投资 | SEC |
| AyurMaya Capital Management Company, LP, David E. Goel ×4 申报 | 2026年7月2日 | 12.30% | 修订 | — | SEC |
| Samsara BioCapital, L.P., Samsara BioCapital GP, LLC, Samsara Opportunity Fund, L.P., Samsara Opportunity Fund GP, LLC, Srinivas Akkaraju ×5 申报 | 2026年1月13日 | 5.40% | 修订 | — | SEC |
| Foresite Capital Fund VI, L.P. (“Fund VI”), Foresite Capital Management VI, LLC (“FCM VI”), Foresite Capital Fund V, L.P. (“Fund V”), Labs Co-Invest V, LLC (“Labs Co-Invest”), Foresite Capital Management V, LLC (“FCM V”), Foresite Capital Opportunity Fund V, L.P. (“Opportunity Fund V”), Foresite Capital Opportunity Management V, LLC (“FCOM V”), Foresite Labs Fund I, L.P. (“Labs Fund I”), Foresite Labs Management I, LLC (“FLM I”), Foresite Labs Affiliates 2021, LLC (“Labs Affiliates”), Foresite Labs, LLC (“Labs”), James B. Tananbaum (“Tananbaum”) | 2024年7月5日 | — | 初始申报 | 被动投资 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 38 只交易所交易基金持有
权重仅反映直接股权持仓(N-PORT);杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 1.59% | 24020 NS | 2026年4月30日 | N-PORT |
| PILL · Direxion Shares ETF Trust | 1.25% | 6551 NS | 2026年4月30日 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund ... | 0.54% | 2446 NS | 2026年4月30日 | N-PORT |
| IHE · iShares Trust | 0.52% | 304339 SH | 2026年8月8日 | 每日 |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.23% | 6715 SH | 2026年8月8日 | 每日 |
| VFMO · VANGUARD WELLINGTON FUND | 0.18% | 126318 SH | 2026年8月8日 | 每日 |
| IBB · iShares Trust | 0.18% | 613997 SH | 2026年8月8日 | 每日 |
| BIB · ProShares Trust | 0.14% | 4674 NS | 2026年5月31日 | N-PORT |
| IWO · iShares Trust | 0.14% | 718737 SH | 2026年8月8日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.13% | 84673 SH | 2026年8月8日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.10% | 99832 SH | 2026年8月8日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.07% | 454674 SH | 2026年8月8日 | 每日 |
| IWM · iShares Trust | 0.07% | 2015040 SH | 2026年8月8日 | 每日 |
| SMMV · iShares Trust | 0.06% | 6398 SH | 2026年8月8日 | 每日 |
| ESML · iShares Trust | 0.06% | 61746 SH | 2026年8月8日 | 每日 |
| ITWO · ProShares Trust | 0.04% | 3225 NS | 2026年5月31日 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.04% | 389927 NS | 2026年5月31日 | N-PORT |
| ISCB · iShares Trust | 0.03% | 3324 SH | 2026年8月8日 | 每日 |
| VXF · VANGUARD INDEX FUNDS | 0.03% | 976842 SH | 2026年8月8日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.03% | 203834 SH | 2026年8月8日 | 每日 |
| GSSC · Goldman Sachs ETF Trust | 0.03% | 11873 NS | 2026年5月31日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.03% | 29655 NS | 2026年4月30日 | N-PORT |
| UWM · ProShares Trust | 0.02% | 2523 NS | 2026年5月31日 | N-PORT |
| WSML · iShares Trust | 0.02% | 3939 SH | 2026年8月8日 | 每日 |
| URTY · ProShares Trust | 0.02% | 2551 NS | 2026年5月31日 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.01% | 9842 NS | 2026年5月31日 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0.01% | 33350 NS | 2026年5月31日 | N-PORT |
| HDG · ProShares Trust | 0.01% | 64 NS | 2026年5月31日 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.01% | 1965 NS | 2026年5月31日 | N-PORT |
| ITOT · iShares Trust | 0.00% | 113351 SH | 2026年8月8日 | 每日 |
| IWV · iShares Trust | 0.00% | 22996 SH | 2026年8月8日 | 每日 |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 46445 NS | 2026年5月31日 | N-PORT |
| AVSU · AMERICAN CENTURY ETF TRUST | 0.00% | 60 NS | 2026年5月31日 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0.00% | 1484 NS | 2026年5月31日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 612 NS | 2026年4月30日 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 3140764 SH | 2026年8月8日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 6510 SH | 2026年8月8日 | 每日 |
| DFAT · Dimensional ETF Trust | 0.00% | 1 NS | 2026年4月30日 | N-PORT |